Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,148 public trials 1,871 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Completed

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

NCT03631784

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • St Joseph Heritage Healthcare ( Site 1403) Santa Rosa, California, United States
  • North Shore University Health System ( Site 1413) Evanston, Illinois, United States
  • Parkview Cancer Institute ( Site 1415) Fort Wayne, Indiana, United States
  • UMass Memorial Medical Center ( Site 1417) Worcester, Massachusetts, United States
View all 56 locations
View Trial Details
Completed

Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC

NCT03526887

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • H. Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
  • Consorci Sanitari de Terrassa Terrassa, Barcelona, Spain
View all 19 locations
View Trial Details
Completed

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

NCT03046992

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +14 more
Locations
  • The Catholic University of Korea, Bucheon St. Mary's Hospital Bucheon-si, Gyeonggi-do, South Korea
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
  • CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
View all 16 locations
View Trial Details
Completed

Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)

NCT02437136

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • University of Maryland, Marlene and Stewart Greenbaum Cancer Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment

NCT04256707

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Hadassah Ein Karem University Hospital Jerusalem, Israel
  • University Hospital Assuta Ashdod Ashdod, Israel
  • Soroka University Medical Center Beersheba, Israel
  • Oncology Department Hillel Yaffe Medical Center Hadera, Israel
View Trial Details

Related conditions